| Literature DB >> 26078560 |
Thomas R McCarty1, Tarun Rustagi1.
Abstract
Gastroparesis has traditionally been a largely medically managed disease with refractory symptoms typically falling under the umbrella of the surgical domain. Surgical options include, but are not limited to, gastrostomy, jejunostomy, pyloromyotomy, or pyloroplasty, and the Food and Drug Administration approved gastric electrical stimulation implantation. Endoscopic management of gastroparesis most commonly involves intrapyloric botulinum toxin injection; however, there exists a variety of endoscopic approaches on the horizon that have the potential to radically shift standard of care. Endoscopic management of gastroparesis seeks to treat delayed gastric emptying with a less invasive approach compared to the surgical approach. This review will serve to highlight such innovative and potentially transformative, endoscopic interventions available to gastroenterologists in the management of gastroparesis.Entities:
Keywords: Botulinum; Gastric pacemaker; Gastric stimulator; Gastrojejunostomy; Pyloromyotomy; Stenting; Transpyloric
Mesh:
Substances:
Year: 2015 PMID: 26078560 PMCID: PMC4462724 DOI: 10.3748/wjg.v21.i22.6842
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742